Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

AHA 2022: get the interventional cardiology perspective!

07 Nov 2022

Stay up to date with what is new and hot in interventional cardiology at #AHA22 in Chicago.

PCRonline @ AHA 2022

A patient with diabetes and diffuse coronary disease – how should I treat small vessels?

31 Oct 2022

For this 2nd PCR Webinar on the Road, join your duo of hosts D. Milasinovic and C. de Biase in the cathlab with A. Latib in New York, U.S.A

A patient with diabetes and diffuse disease – how should I treat small vessels?

How and when should I consider Drug Coated Balloons to treat de novo lesions?

31 Oct 2022

Discover the replay of this PCR Webinar on Drug Coated Balloons with F. Ribichini, F. Manterola and D. Mylotte.

How and when should I consider Drug Coated Balloons to treat de novo lesions ?

#1 - How should I treat a patient with in-stent restenosis ?

31 Oct 2022

Discover the replay of this PCR Webinar on drug-coated-balloons with F. Ribichini, B. Scheller and A. G. Zaman

How should I treat a patient with in-stent restenosis ?

Drug Coated Balloons 2021-2022

31 Oct 2022

Find out more about this new series of 2 PCR Webinars on drug coated balloons

Drug Coated Balloons Coronary Intervention Series

A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study

24 Oct 2022

The purpose of the ROLEX Registry (Revascularization Of LEft main with resolute onyX) was to explore outcomes using a more contemporary drug eluting stent platform which is more suitable for LM PCI.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study

How to avoid and manage complications - Rupture and perforation

In this case-based discussion, learn with experts how to avoid major complications during PCI such as distal vessel perforation and mid vessel rupture, and through algorithms, how to manage them in case they occur.

Complications - Rupture and perforation

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Precision PCI - Simplifying the complex - Learn from the masters

07 Oct 2022 – From AICT-ASIAPCR 2022

This session will help you better understand the influence of stent design, drug and polymer on the procedural short and long-term outcomes, the use of OCT in PCI of complex coronary lesions and the role, prevalence and diagnosis of microvascular dysfunction in patients with ischaemia and...

Precision PCI - Simplifying the complex - Learn from the masters